Piper Sandler upgraded shares of Trupanion (NASDAQ:TRUP – Free Report) from a neutral rating to an overweight rating in a report published on Thursday morning, Marketbeat Ratings reports. They currently have $57.00 price objective on the financial services provider’s stock.
A number of other equities research analysts have also weighed in on TRUP. Stifel Nicolaus boosted their price objective on shares of Trupanion from $42.00 to $44.00 and gave the stock a “hold” rating in a report on Monday, January 6th. Northland Securities boosted their price target on shares of Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research note on Thursday, October 31st. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Trupanion currently has an average rating of “Moderate Buy” and a consensus target price of $45.33.
Read Our Latest Analysis on TRUP
Trupanion Stock Up 3.8 %
Trupanion (NASDAQ:TRUP – Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.09. The firm had revenue of $327.50 million during the quarter, compared to analysts’ expectations of $321.79 million. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The company’s revenue for the quarter was up 14.6% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.10) EPS. Sell-side analysts forecast that Trupanion will post -0.2 EPS for the current fiscal year.
Insider Buying and Selling at Trupanion
In other Trupanion news, CFO Fawwad Qureshi sold 9,867 shares of the business’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $53.08, for a total transaction of $523,740.36. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP Emily Dreyer sold 3,100 shares of the firm’s stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $54.85, for a total transaction of $170,035.00. Following the completion of the sale, the senior vice president now directly owns 24,708 shares of the company’s stock, valued at approximately $1,355,233.80. This represents a 11.15 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 28,597 shares of company stock valued at $1,522,082 in the last 90 days. Insiders own 5.50% of the company’s stock.
Institutional Investors Weigh In On Trupanion
Hedge funds have recently made changes to their positions in the company. GAMMA Investing LLC lifted its position in Trupanion by 18.5% during the fourth quarter. GAMMA Investing LLC now owns 1,709 shares of the financial services provider’s stock valued at $82,000 after buying an additional 267 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Trupanion by 7.3% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,861 shares of the financial services provider’s stock worth $414,000 after acquiring an additional 671 shares in the last quarter. JPMorgan Chase & Co. lifted its position in Trupanion by 2.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 28,317 shares of the financial services provider’s stock valued at $1,189,000 after acquiring an additional 738 shares during the period. Quest Partners LLC bought a new stake in Trupanion during the third quarter worth about $37,000. Finally, Check Capital Management Inc. CA grew its holdings in Trupanion by 2.7% in the third quarter. Check Capital Management Inc. CA now owns 41,460 shares of the financial services provider’s stock worth $1,740,000 after purchasing an additional 1,100 shares during the period.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Recommended Stories
- Five stocks we like better than Trupanion
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- What is the Euro STOXX 50 Index?
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.